$IBIO Cashflow Statement | Understand Stock

$IBIO

$0.71 -$0.01 (1.5%) Close

$IBIO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2026 12 months to Jun 30, 2026	FY2025 12 months to Jun 30, 2025	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022
Cash flows from operating activities:
Net loss
Adjustments to reconcile consolidated net loss to net cash used in operating activities:
Share-based compensation
Amortization of intangible assets
Amortization of finance lease right-of-use assets
Amortization of operating lease right-of-use assets
Depreciation of fixed assets
Gain on sale of fixed assets
Gain on extinguishment of debt
Accrued interest receivable on promissory note receivable
Amortization of premiums on debt securities
Loss on sale of debt securities
Amortization of deferred financing costs
Inventory reserve
Fixed asset impairments
Gain on sale of intangible assets
Amortization of premiums/(accretion of discounts) on debt securities, net
Provision for credit losses
Impairment of fixed assets
Impairment of intangible assets
Forgiveness of note payable and accrued interest - SBA loan
Settlement of revenue contract
Impairment of investment in equity security
Gain on disposition of finance lease ROU assets
Changes in operating assets and liabilities:
Accounts receivable - trade
Settlement receivable
Inventory
Prepaid expenses and other current assets
Prepaid expenses - noncurrent
Security deposit
Accounts payable
Accrued expenses
Accrued expenses - noncurrent
Operating lease obligations
Contract liabilities

Net cash used in operating activities
Cash flows from investing activities:
Purchases of debt securities
Redemption of debt securities
Sale of debt securities
Purchase of equity security
Additions to intangible assets
Payment received for interest and principal on promissory note receivable
Sale proceeds for intangible assets
Purchases of fixed assets
Sales proceeds for fixed assets
Payment for RubrYc asset acquisition
Net cash (used in) provided by investing activities

Cash flows from financing activities:
Acquisition of noncontrolling interest
Proceeds from sales of common stock
Proceeds from Warrant Inducement
Payments for fractional shares after reverse stock split
Proceeds from sales of pre-funded warrants
Proceeds from the exercise of warrants for pre-funded warrants
Proceeds from the exercise of warrants for common stock
Payments made for costs to acquire capital
Proceeds from equipment financing loan
Proceeds from Warrant Inducement Transaction
Proceeds from the exercise of stock options
Costs to attain term note
Subscription receivable
Payment of equipment financing loan
Proceeds from term promissory note
Payment of term promissory note
Payment of term note payable
Payments made for costs to attain term note
Payment of finance lease obligation
Net cash provided by financing activities

Effect of exchange rate changes
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash - beginning
Cash, cash equivalents and restricted cash - end
Subscription receivable
Costs to raise capital paid directly from gross proceeds
Insurance premium financing
Costs to raise capital included in accrued expenses
Reserves related to term promissory note included in prepaid expenses
Costs related to term promissory note paid directly from gross proceeds
Cost accrued to amend term note payable
Unpaid fixed assets included in accounts payable
Termination of finance ROU assets including issuance of warrant
Note payable to acquire Facility
Increase in operating lease ROU assets for new lease - net of lease incentive
Settlement of revenue contract
Issuance of warrant for final finance lease obligation payment
Lease incentive for construction in progress
Acquisition of noncontrolling interest
Unrealized (gain) loss on available-for-sale debt securities
Fixed assets included in accounts payable in prior period, paid in current period
Increase in finance lease ROU assets for new leases
Increase in finance lease obligation for new leases
RubrYc asset acquisition by issuance of common stock
Issuance of warrant for term note payable obligation
Unrealized loss (gain) on available-for-sale debt securities
Schedule of non-cash activities:
Costs to raise capital included in accrued expenses
Issuance of warrant for term note payable obligation
Reserves related to term promissory note included in prepaid expenses
Costs related to tern promissory note paid directly from gross proceeds
Unrealized loss on available-for-sale debt securities
Unpaid fixed assets in accounts payable
Indefinite-lived intangible asset addition
Shares issued to AstralBio for license fee
Credit provided by AstralBio
Insurance premium financing
Subscription receivable
Costs to raise capital paid directly from gross proceeds
Supplemental cash flow information:
Cash paid during the year for interest

Comments